Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.15 USD | -4.03% | -7.50% | -41.58% |
05-09 | Pulse Biosciences, Inc. Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode System | CI |
05-07 | Transcript : Pulse Biosciences, Inc., Q1 2024 Earnings Call, May 07, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-41.58% | 411M | |
+11.29% | 226B | |
+8.76% | 188B | |
+12.90% | 137B | |
+25.95% | 108B | |
+0.34% | 63.19B | |
+11.08% | 52.26B | |
+5.62% | 51B | |
+6.28% | 43.89B | |
+4.80% | 38.07B |
- Stock Market
- Equities
- PLSE Stock
- News Pulse Biosciences, Inc.
- Pulse Biosciences Gets FDA Clearance For Percutaneous Electrode System